Latest News and Updates

After co-leading the $70M Series A alongside Polaris & D1 Capital and doubling down on the $90M Series B, OCV is incredibly proud to share that our portfolio company ByHeart is the first new infant formula manufacturer in over 15 years to be registered with FDA,...

Ockam builds open-source developer-first tools for mutual authentication and end-to-end encrypted messaging between distributed applications, in any environment, anywhere… Trust Data-in-Motion.   Ockam has secured $12.5 million of Series A funding from OCV,...

Rad AI, the fastest growing radiologist-led AI company, today announced $25 million in Series A funding. The round was led by Artis Ventures with participation from several existing investors, including OCV Partners, Kickstart Fund, and Gradient Ventures (Google's...

SafeBreach, the pioneer in breach and attack simulation, today announced that it has raised $53.5 million in Series D funding, led by Sonae IM and Israel Growth Partners (IGP), with additional participation from new investors Sands Capital and Leumi Partners, as well...

Congratulations to our portfolio company ByHeart on being the first and only infant formula company in the US to receive the “Clean Label Project Purity Award” certification from the Clean Label Project. The Clean Label Project screened ByHeart’s formula for over 500...

OCV congratulates Dr. Chris Bostick on receiving the Biocom Life Science Catalyst Award. Chris is a General Partner at OCV Partners with over a decade of interdisciplinary research experience. Chris joined OCV in 2018 and has provided his expertise and leadership to...

OCV Partners (“OCV”) announced today that Dr. Chris Bostick has been promoted to General Partner. Chris joined OCV in 2018 and has provided his expertise and leadership to all of our healthcare investments as well as contributing to many of our non-healthcare...

ByHeart - the only new entrant to the US market to build its infant formula recipe entirely from scratch - achieves all of its clinical trial endpoints in the largest and most comprehensive clinical trial from a new infant formula brand in 25 years, further cementing...

Mobile-first AR solution empowers businesses to transact from anywhere.Expands Bill.com’s footprint to serve international markets. Read Full Story on Businesswire.com SAN JOSE, Calif.--(BUSINESS WIRE)--Bill.com (NYSE:BILL), a leading provider of cloud-based software...

ByHeart is expected to be the first new entrant to the market to build its own manufacturing facility, supply chain and infant formula blend that is based on decades of breast milk research and modern advancements in nutrition science. NEW YORK, June 2,...

Tel Aviv’s Orca AI, a computer vision startup that can be retrofitted to cargo ships and improve navigation and collision avoidance, has raised $13 million in a Series A funding, taking its total raised to over $15.5 million. While most cargo ships carry security...

SOMERVILLE, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally...